BioSpace News Archive

Beta Bionics, Inc. announced the appointments of Gilad Glick, former Chief Executive Officer, Itamar Medical, to the Board of Directors and Veena Rao, Ph.D., to the role of Chief Commercial Officer.

Haemonetics Corporation announced that it will host an Investor Day in Boston on Wednesday, June 29, 2022 beginning at 10:00 AM EDT.

DNA Script, a world leader in Enzymatic DNA Synthesis for DNA on demand, has added life sciences veteran Chris Barbazette as Chief Commercial Officer to its leadership team.

Aurinia Pharmaceuticals Inc. issued its financial results for the first quarter ended March 31, 2022.

Domain Therapeutics announced the closing of a US $42m series A financing round co-led by Panacea Venture, CTI Life Sciences and 3B Future Health Fund, and joined by adMare BioInnovations, Schroders Capital, Omnes, Turenne Capital, Theodorus, Viva BioInnovator and existing investor Seventure Partners.

Immuneering Corporation, a biopharmaceutical company using translational bioinformatics to advance a pipeline of product candidates designed to benefit large populations of patients with cancer and other diseases, reported financial results for the first quarter ended March 31, 2022 and provided recent business highlights.

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced financial results for the first quarter of 2022 and provided an update on the Company’s business operations and clinical development programs.

Merck, known as MSD outside the United States and Canada, announced that data for six approved medicines and pipeline candidates in more than 25 types of cancer will be presented at the 2022 American Society of Clinical Oncology Annual Meeting in Chicago from June 3-7.

Biohaven Pharmaceutical Holding Company Ltd. reported financial results for the first quarter ended March 31, 2022, and provided a review of recent accomplishments during and anticipated upcoming milestones.

Agios Pharmaceuticals, Inc. announced that the company is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 17, 2022, at 10:30 a.m. ET.